Manuel ELLERMANN

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2025-05-29

Top Assignees for applications by Manuel ELLERMANN

The entities that hold a legal rights for patent applications filed by inventor ELLERMANN Manuel:

Bayer Pharma Aktiengesellschaft 15 Berlin, Germany
THE BROAD INSTITUTE, INC. 8 Cambridge, MA United States
Bayer Aktiengesellschaft 8 Leverkusen, Germany
Dana-Farber-Cancer Institute, Inc. 6 Boston, MA United States

Recent patent applications by ELLERMANN Manuel

Manuel ELLERMANN from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-29

US20250170136A1

Human necessities

1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

#2 | 2024-06-06

US20240182452A1

Chemistry; metallurgy

6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER

#3 | 2023-01-19

US20230017200A1

Chemistry; metallurgy

Dihydrooxadiazinones

#4 | 2022-12-15

US20220396554A1

Chemistry; metallurgy

Dihydrooxadiazinones

#5 | 2021-11-18

US20210353630A1

Human necessities

1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

#6 | 2020-11-26

US20200369633A1

Chemistry; metallurgy

Dihydrooxadiazinones

#7 | 2020-08-06

US20200247783A1

Chemistry; metallurgy

6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer

#8 | 2020-02-27

US20200062741A1

Chemistry; metallurgy

Compounds, compositions and methods for cancer treatment

#9 | 2017-11-23

US20170334917A1

Chemistry; metallurgy

Piperidinylpyrazolopyrimidinones and their use

#10 | 2016-09-29